Pharmacokinetics of ABBV-951 Following 24-Hour Continuous Subcutaneous Infusion to Arm, Abdomen and Thigh
Objective: Characterize levodopa pharmacokinetics (PK) and safety/tolerability of ABBV-951 in healthy volunteers at 3 different subcutaneous (SC) infusion sites: Arm, Abdomen and Thigh Background: As…Resting-state EEG functional connectivity in Parkinson’s disease
Objective: To examine EEG functional connectivity (FC) between brain regions during resting wakefulness as a function of cognitive status in PD. Background: Progressive cognitive decline…Drooling in Parkinson’s Disease: A [123I]FP-CIT SPECT study
Objective: Evaluate the association between drooling and striatal dopamine terminals. Test the assumption that drooling correlates with disease progression in de novo Parkinson’s disease (PD)…Association between quality of life and physical functions in patients with idiopathic Parkinson’s disease
Objective: The aim was to investigate the association between health-related quality of life and physical functions in the patients with idiopathic Parkinson's disease (PD). Background:…131-MIBG is less promising in differentiating Parkinson’s disease from other parkinsonism for early onset patients
Objective: To investigate the diagnostic value of 131I-MIBG cardiac scintigraphy in differentiating PD from other parkinsonism for distinct age of onset. Background: MIBG cardiac sympathetic imaging has…Levodopa Induced dyskinesia in patients with Parkinson’s disease and polymorphisms gene DRD3 dopamine receptor
Objective: The aim of this study was to investigate the association between two DRD3 gene single-nucleotide polymorphisms (SNPs) and the development of LID in patients…Neuroprotective actions of red propolis extract and formononetin in a rat model of Parkinson’s disease
Objective: To evaluate the effects of the hydroalcoholic extract of red propolis (HERP) and one of its major compounds, formononetin (FN), against the motor symptoms…Oscillaotory activity in the globus pallidus internus in patients with Parkinson’s disease
Objective: To quantify the characteristics of oscillatory neurons in the GPi in patients with PD. Background: Abnormal oscillatory activity has been predicted to play a…Mindfulness Training to Reduce Anxiety in Parkinson’s Disease: A Cautionary Tale about Wearable Technology
Objective: This study aimed to determine the feasibility of using a non-pharmacologic intervention (mindfulness training; MT) administered with a wearable tracker to alleviate anxiety through…Motor and non-motor symptoms related to sleep disturbances in Parkinson’s disease
Objective: To assess which (non-)motor symptoms are associated with the longitudinal development of sleep disturbances, one of the major non-motor symptoms (NMS) in Parkinson’s disease…
- « Previous Page
- 1
- …
- 141
- 142
- 143
- 144
- 145
- …
- 388
- Next Page »